Cancer Cell Membrane‐Based Materials for Biomedical Applications

Abstract The nanodelivery system provides a novel direction for disease diagnosis and treatment; however, its delivery effectiveness is restricted by the short biological half‐life and inadequate tumor targeting. The immune evasion properties and homologous targeting capabilities of natural cell membranes, particularly those of cancer cell membranes (CCM), have gained significant interest. The integration of CCM and nanoparticles has resulted in the emergence of CCM‐based nanoplatforms (CCM‐NPs), which have gained significant attention due to their unique properties. CCM‐NPs not only prolong the blood circulation time of core nanoparticles, but also direct them for homologous tumor targeting. Herein, the history and development of CCM‐NPs as well as how these platforms have been used for biomedical applications are discussed. The application of CCM‐NPs for cancer therapy will be described in detail. Translational efforts are currently under way and further research to address key areas of need will ultimately be required to facilitate the successful clinical adoption of CCM‐NPs.